Use of xenogeneic islets in hybrid artificial pancreas for treatment of diabetes without immunosuppression.
Ohzato
H
H
Division of Organ Transplantation, New England Deaconess Hospital, Harvard Medical School, Boston, Massachusetts 02215.
Carretta
M
M
Maki
T
T
Sullivan
S J
SJ
Borland
K
K
Muller
T E
TE
Solomon
B A
BA
Chick
W L
WL
Monaco
A P
AP
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight; D002417:Cattle; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000188:drug therapy / Q000601:surgery*; D004285:Dogs; D005260:Female; D007332:Insulin Infusion Systems; D049528:Insulin, Long-Acting / Q000627:therapeutic use; D016381:Islets of Langerhans Transplantation / Q000379:methods* / Q000502:physiology; D010180:Pancreatectomy; D014183:Transplantation, Heterologous / Q000379:methods / Q000502:physiology
D001786:Blood Glucose; D049528:Insulin, Long-Acting